Refine
Year of publication
Document Type
- Preprint (772)
- Article (725)
- Working Paper (6)
- Conference Proceeding (3)
- Doctoral Thesis (3)
- Report (2)
Has Fulltext
- yes (1511)
Is part of the Bibliography
- no (1511)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron scattering (experiments) (12)
- Hadron-Hadron Scattering (11)
- LHC (9)
- Heavy-ion collision (6)
- Heavy-ion collisions (5)
- ALICE experiment (4)
- Bone density (4)
- COVID-19 (4)
- Cancer (4)
- Collective Flow (4)
- Computed tomography (4)
- Depression (4)
- Jets (4)
- Magnetic resonance imaging (4)
- Osteoporosis (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Biomarkers (3)
- Diffraction (3)
- Epilepsy (3)
- Genetics (3)
- Heavy Ions (3)
- Heavy Quark Production (3)
- Jets and Jet Substructure (3)
- Multidetector computed tomography (3)
- Seizure (3)
- Spine (3)
- acute myeloid leukemia (3)
- pp collisions (3)
- Accelerators & Beams (2)
- Acute myeloid leukemia (2)
- Algorithms (2)
- Artificial intelligence (2)
- Atomic, Molecular & Optical (2)
- Beam Energy Scan (2)
- Beauty production (2)
- Biomarker (2)
- Bipolar disorder (2)
- CT (2)
- CV9202 (2)
- Charm physics (2)
- Chiral Magnetic Effect (2)
- Cohort studies (2)
- Collectivity (2)
- Correlation (2)
- Costs (2)
- Diagnostic imaging (2)
- Elastic scattering (2)
- Elliptic flow (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- FGFR (2)
- Frieden (2)
- Friedenskonferenz (2)
- Immunology (2)
- Intensive care units (2)
- Lepton-Nucleon Scattering (experiments) (2)
- MRI (2)
- MSC (2)
- MSC2013 (2)
- Mitochondria (2)
- München (2)
- Neoplasms (2)
- Non-small cell lung cancer (2)
- Oncology (2)
- Osteoporotic fractures (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Positron emission tomography (2)
- Pre-analytics (2)
- Psychiatric disorders (2)
- QCD (2)
- Quality of life (2)
- Quarkonium (2)
- Relativistic heavy-ion collisions (2)
- SARS-CoV-2 (2)
- Shear viscosity (2)
- Sicherheitskonferenz (2)
- Single electrons (2)
- Surgery (2)
- Tomography (2)
- Tomography (x-ray computed) (2)
- Vasculitis (2)
- apoptosis (2)
- cabozantinib (2)
- childhood acute myeloid leukemia (2)
- cirrhosis (2)
- computed tomography (2)
- growth inhibition (2)
- immunotherapy (2)
- land use (2)
- liver (2)
- lung cancer (2)
- penile cancer (2)
- portal hypertension (2)
- relapse (2)
- resistant cell lines (2)
- salvage therapy (2)
- security conference (2)
- squamous cell carcinoma (2)
- storage rings (2)
- targeted therapy (2)
- 19F (1)
- 3 mm RAS instruments (1)
- 3 mm instruments (1)
- 3years (1)
- 8 weeks (1)
- 900 GeV (1)
- ABCB1 (1)
- ABCC1 (1)
- ABCG2 (1)
- ACLF (1)
- ADGRE1 (1)
- AKI (1)
- AKT (1)
- ALICE detector (1)
- ALK-rearranged NSCLC (1)
- APRI (1)
- Ablation Techniques (1)
- Accelerators & storage rings (1)
- Acquired drug resistance (1)
- Acquired resistance (1)
- Active middle ear implants (1)
- Acuris (1)
- Acute lymphoblastic leukemia (1)
- Acute lymphocytic leukaemia (1)
- Adolescents (1)
- Age determination by skeleton (1)
- Age groups (1)
- Aktienmarkt (1)
- Alpha-synuclein (1)
- Alternative oxidase (1)
- Alzheimer (1)
- Amino acid analysis (1)
- Amyloid precursor protein (1)
- Anemia (1)
- Angiography (1)
- Angiomyolipoma (1)
- Anterior cruciate ligament (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Anticonvulsant (1)
- Antifungal agents (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Aortic valve replacement (1)
- Applikationen (1)
- Archaeogeophysics (1)
- Artificial Intelligence (1)
- Aspergillosis (1)
- Atomic & molecular beams (1)
- Auditory system (1)
- Autofreies Wohnen (1)
- Autologous stem cell transplantation (1)
- Automated Tube Potential Selection (1)
- Autoreduziertes Wohnen (1)
- Awareness campaign (1)
- B cell receptor (1)
- B-slope (1)
- BI1361849 (1)
- Beam energy scan (1)
- Beam loss (1)
- Behavior (1)
- Behavioral disorders (1)
- Bike-Sharing (1)
- Biodiversity (1)
- Biodiversity Data (1)
- Biogeochemistry (1)
- Biological heart valves (1)
- Biomonitoring (1)
- Bioprosthesis (1)
- Biopsy (1)
- Bleeding (1)
- Blood (1)
- Blood sample handling (1)
- Bloodstream infections (1)
- Bone conduction devices (1)
- Bone disease (1)
- Bone diseases (1)
- Bone diseases, Metabolic (1)
- Bone marrow (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Brachiopoda (1)
- Brachiozoa (1)
- Breathing (1)
- Bryozoa (1)
- Business strategy in drug development (1)
- C-reactive protein (1)
- CABG (1)
- CAC-DRS Score (1)
- CAD/ CAM crown (1)
- CAKUT (1)
- CNDAC (1)
- COMT (1)
- CRPC (1)
- CT dual-energy computed tomography (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CT-guidance (1)
- CTLA-4 (1)
- Calcium (1)
- Cancer Staging (1)
- Cancer check up (1)
- Cancer staging (1)
- Car-Sharing (1)
- Carbon cycle (1)
- Cardiac surgery (1)
- Carsharing (1)
- Cell membranes (1)
- Central Europe (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Charge-transfer collisions (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Checkpoint inhibitor (1)
- Chemicals of emerging concern (1)
- Chemoembolization (1)
- Chemotherapy (1)
- Child abuse (1)
- Childhood abuse (1)
- Children (1)
- Chiral magnetic effect (1)
- Chondral Lesion (1)
- Circular accelerators (1)
- Cirrhosis (1)
- Cleanliness level (1)
- Climate-change ecology (1)
- Clinical genetics (1)
- Clinical trial (1)
- Clinical variation (1)
- Coalescence (1)
- Cochlear implantation (1)
- Cold nuclear matter effects (1)
- Collagen Maps (1)
- Collective Flow, (1)
- Colon capsule endoscopy (1)
- Combined immune checkpoint blockade (1)
- Combo® DTS (1)
- Community ecology (1)
- Comparison with QCD (1)
- Complementation rate (1)
- Complex II (1)
- Complex posttraumatic stress disorder (1)
- Compositional bias (1)
- Computed Tomography (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computed tomography, X-ray (1)
- Computer-aided drug design (1)
- Cone-beam computed tomography (1)
- Congenital anomalies (1)
- Consensus statement (1)
- Conservation (1)
- Conservation biology (1)
- Contrast agent (1)
- Coronary Heart Disease (1)
- Coronary Plaque Burden (1)
- Couch tracking (1)
- Critical point (1)
- Cryoelectron microscopy (1)
- DCK (1)
- DECT (1)
- DME (1)
- DNA sequence analysis (1)
- DNA taxonomy (1)
- DNA-PAINT (1)
- DSM (1)
- Darmstadt (1)
- Data sharing (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- Diagnostic accuracy (1)
- Diagnostic markers (1)
- Dialectical behavioural therapy (1)
- Digitization (1)
- Direct oral anticoagulation (1)
- Direct reactions (1)
- Drug screens (1)
- Drug therapy (1)
- Dual-Source CT (1)
- Dual-energy computed tomography (1)
- EGFR (1)
- EMR1 (1)
- ETP-ALL (1)
- East–west divide (1)
- Eating disorders (1)
- Ecological modelling (1)
- Ecological networks (1)
- Ecosystem ecology (1)
- Ectoprocta (1)
- Edema (1)
- Elderly (1)
- Electric stimulation (1)
- Electron-pion identification (1)
- Electronic transitions (1)
- Electroweak interaction (1)
- Elektromobilität (1)
- Ellenberg indicator values (1)
- Embryos (1)
- Endocannabinoids (1)
- Endovascular aortic repair (1)
- Environmental impact (1)
- European stock markets (1)
- Europäische Aktienmärkte (1)
- Europäische Union (1)
- Everolimus (1)
- Evidence-based guidelines (1)
- Exudates and transudates (1)
- Eye movements (1)
- F4/80 (1)
- FBS (1)
- FFLU (1)
- FIB-4 (1)
- FLT3 (1)
- Facial nerve (1)
- Fahrradverleihsysteme (1)
- Feasibility studies (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Flottenkonzepte (1)
- Forest ecology (1)
- Forschung (1)
- Forward physics (1)
- Frailty (1)
- Full waveform (1)
- Functional outcomes (1)
- GPS collar (1)
- GWAS (1)
- Gastrointestinal (1)
- Gene expression (1)
- General practitioners (1)
- Gimbaled tracking (1)
- Glioblastoma survival (1)
- Global positioning system (1)
- Gram negative bacteria (1)
- Groomed jet radius (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- HBT (1)
- HBV (1)
- HCC (1)
- HIV (1)
- HIV-1 (1)
- HNO (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronization (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Head and neck cancer (1)
- Health information (1)
- Health policy (1)
- Health-seeking behaviour (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion collisions (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Hedgehog pathway (1)
- Helpline (1)
- Hematologic malignancies (1)
- Hematology (1)
- Hematopoietic stem cell transplantation (1)
- Hepatitis C virus (1)
- Herbaria (1)
- Herniated disk (1)
- Hif-1 alpha (1)
- High-dose chemotherapy (1)
- Higher moments (1)
- Hodgkin lymphoma (1)
- Hsp70 (1)
- Hypertension (1)
- Hypochondriasis (1)
- Hypofractionated radiotherapy (1)
- ICL (1)
- ICL V4c (1)
- IHC (1)
- ILUVIEN (1)
- INR (1)
- Image processing (1)
- Image processing (computer-assisted) (1)
- Immunogenetics (1)
- Immunomonitoring (1)
- In-TIPS thrombosis (1)
- Inclusive spectra (1)
- Incomplete colonoscopy (1)
- Inflammation (1)
- Intensity interferometry (1)
- Interference fragmentation function (1)
- International normalized ratio (1)
- Interpretation (1)
- Intervertebral disc displacement (1)
- Intrinsic resistance (1)
- Invariant Mass Distribution (1)
- Invasive candidiasis (1)
- Inversion (1)
- Ionisation energy loss (1)
- Ipilimumab (1)
- J/ψ suppression (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jet substructure (1)
- K3EDTA plasma sampling (1)
- KDIGO (1)
- Kidney (1)
- Knee joint (1)
- Knockout (1)
- Kryptrochozoa (1)
- LVSPE (1)
- Ladeinfrastruktur (1)
- Lehre (1)
- Lenalidomide (1)
- Leukemia (1)
- Leukemias (1)
- Library screening (1)
- Lincoln-Siedlung (1)
- Lipidol (1)
- Lipidomics (1)
- Liver (1)
- Liver diseases (1)
- Liver transplantation (1)
- Local control (1)
- Lophophorata (1)
- Low & intermediate-energy accelerators (1)
- Low volume prep (1)
- Low-molecular-weight heparin (1)
- Luciferase (1)
- Lumbar Disk Degeneration (1)
- MALAT1 (1)
- MEDIC (1)
- MLC tracking (1)
- MTOR inhibitor (1)
- MYC (1)
- Magnetic resonance Imaging (1)
- Mass spectrometry (1)
- Mastoiditis (1)
- Material budget (1)
- Medical Oncology (1)
- Medical Physics: Diagnostic (1)
- Melanoma (1)
- Mental health and psychiatry (1)
- Meriç River (1)
- Metabolic (1)
- Metabolomics (1)
- Metastasis (1)
- Micropollutants (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Mitfahrangebote (1)
- Mitochondrial disease (1)
- Mitoxantrone (1)
- Mixed hearing loss (1)
- Mixture risk assessment (1)
- Mobil-Stationen (1)
- Mobilität (1)
- Mobilitätskonzept (1)
- Mobilitätsstationen (1)
- Mobilitätsverhalten (1)
- Model of evolution (1)
- Molecular diagnostic testing (1)
- Monte Carlo (1)
- Moviprep (1)
- Multi-Parton Interactions (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multidetector Computed Tomography (1)
- Multifaktorenmodelle (1)
- Multimodalität (1)
- Multiple factor models (1)
- Multiple myeloma (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- Mutation databases (1)
- Mycoses (1)
- Myocarditis (1)
- Myopia (1)
- NAFLD (1)
- NK cells (1)
- NMR spectroscopy (1)
- NOTCH (1)
- NOTCH1 (1)
- NSF (1)
- NVBP (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Neural network (1)
- Neuronal morphology (1)
- Neuroscience (1)
- Neutropenia (1)
- Nivolumab (1)
- Nuclear modification factor (1)
- Nuclear reactions (1)
- Nuclear structure & decays (1)
- Nucleon induced nuclear reactions (1)
- ORL (1)
- Obsessive-compulsive disorder (1)
- Oldest-old (1)
- Organ motion (1)
- Otorhinolaryngology (1)
- Oxidative phosphorylation (1)
- Oxygen (1)
- PD-1 (1)
- PD-L1 (1)
- PLX4032 (1)
- PLX4720 (1)
- PRoMPT (1)
- PSA screening (1)
- PSA-Screening (1)
- PTEN (1)
- PYTHIA (1)
- Parken (1)
- Parkinson’s disease (1)
- Particle and Resonance Production (1)
- Patellofemoral Joint (1)
- Patterns of care (1)
- Pb–Pb (1)
- Pedelecs (1)
- Personenmobilität (1)
- Phakic (1)
- Phantoms (imaging) (1)
- Phoronida (1)
- Phosphate (1)
- Phospho-soda (1)
- Phosphorylation (1)
- Photon counting (1)
- Phylloscopidae (1)
- Phylloscopus (1)
- Phylogeography (1)
- PillCamColon2 (1)
- Plasma (1)
- Point-of-care testing (1)
- Polarization (1)
- Polyps (1)
- Polysomnography (1)
- Polyzoa (1)
- Positive fluid balance (1)
- Post-processing (1)
- Post-traumatic stress disorder (1)
- Posterior cruciate ligament (1)
- Postoperative atrial fibrillation (1)
- Preventive medicine (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Prostata-specific antigen (1)
- Prostataspezifisches Antigen (1)
- Proton-proton collisions (1)
- Proton–proton (1)
- Proton–proton collisions (1)
- Prävention (1)
- Pseudarthrosis (1)
- Psoriasis vulgaris (1)
- Psychological and psychosocial issues (1)
- Pulmonary embolism (1)
- QGP (1)
- QSARs (1)
- Quantitative Imaging (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- RHIC (1)
- RNA (1)
- RNA, long noncoding (1)
- RNActive (1)
- RSL curve (1)
- Radiation detectors (1)
- Radical prostatectomy (1)
- Radiology (1)
- Radiomics (1)
- Radiotherapy (1)
- Randomised controlled trial (1)
- Rapidity Range (1)
- Rare diseases (1)
- Region Rhein-Main (1)
- Registries (1)
- Rehabilitation (1)
- Relapse (1)
- Relativistic heavy ion physics (1)
- Renal cell carcinoma (1)
- Research (1)
- Research Infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Respiration (1)
- Respiratory chain (1)
- Retro-IDEAL (1)
- Retrospective studies (1)
- Retrospective study (1)
- Rhabdomyoma (1)
- Ribosome (1)
- Risk drivers (1)
- River pollution (1)
- Robotic tracking (1)
- SAMHD1 (1)
- SARS-CoV-2 Pneumonia (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SCCHN (1)
- SLC20A1 (1)
- SMAD (1)
- SPSS (1)
- STAR (1)
- STIR (1)
- Salivary gland carcinoma (1)
- Sampling protocol (1)
- Sapacitabine (1)
- Second-line treatment (1)
- Seicercus (1)
- Semantics (1)
- Senescence (1)
- Sequence (1)
- Serum (1)
- Shell model (1)
- Single muons (1)
- Sleep (1)
- Sleep deprivation (1)
- Small molecules (1)
- Social anxiety disorder (1)
- Sociodemographic characteristics (1)
- SoftDrop (1)
- Specialist training (1)
- Spectroscopic factors & electromagnetic moments (1)
- Spinal fractures (1)
- Spine density (1)
- Splitting function (1)
- Stenotrophomonas maltophilia (1)
- Steroid (1)
- Subependymal giant cell astrocytoma (1)
- Surface waters (1)
- Surveys (1)
- Survival analysis (1)
- Survival data (1)
- Systematic Uncertainty (1)
- Systemic treatment (1)
- T-ALL (1)
- TGFβ (1)
- TGR(mREN2)27 (1)
- TIPS (1)
- TP53 mutation status (1)
- TR (1)
- TSC (1)
- Target screening (1)
- Targeted therapy (1)
- Taxonomy (1)
- Teaching (1)
- Technical data (1)
- Telemedicine (1)
- Territorial songs (1)
- Therapeutic anticoagulation (1)
- Thermal model (1)
- Thoracic aortic aneurysm (1)
- Time Projection Chamber (1)
- Tracking (1)
- Traditional Chinese Medicine (TCM) (1)
- Transcriptome analysis (1)
- Transition radiation detector (1)
- Transjugular Intrahepatic Portosystemic Shunt (1)
- Transverse momentum (1)
- Transversity (1)
- Treatment (1)
- Trigger (1)
- Tyrosine kinase inhibitor mTOR inhibition (1)
- USP28 (1)
- Umweltbilanz (1)
- University hospitals (1)
- Universitätskliniken (1)
- Urinary continence (1)
- Urinary incontinence (1)
- Ursus arctos (1)
- Uveal melanoma (1)
- VEGFR (1)
- Vaccination (1)
- Valve surgery (1)
- Vector Boson Production (1)
- Vemurafenib (1)
- Vesicles (1)
- Vincristine (1)
- Virtual noncalcium reconstructions (1)
- Vorsorgeuntersuchung (1)
- Weiterbildung (1)
- Western diet (1)
- Wohnumzug (1)
- Workstation comparison (1)
- X-ray computed (1)
- X-rays (1)
- Xenon-based gas mixture (1)
- abdominal imaging (1)
- accessory proteins (1)
- acoustic radiation force impulse imaging (1)
- activity sensors (1)
- acute decompensation (1)
- acute lymphoblastic leukemia (1)
- acute-on-chronic liver failure (1)
- adjuvant chemotherapy (1)
- aegean (1)
- age (1)
- amino acids (1)
- amphiregulin (1)
- amygdalin (1)
- anaplastic large cell lymphoma (1)
- angiography (1)
- anterior chamber depth changes (1)
- anti-EGFR therapy (1)
- antiepileptic drugs (1)
- antimicrobial stewardship (1)
- antiviral therapy (1)
- aortic stenosis (1)
- archeological sea-level limiting points (1)
- artesunate (ART) (1)
- artifacts (1)
- artificial intelligence (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- autophagy (1)
- bacterial leakage (1)
- beads (1)
- bioactivity testing (1)
- biogeographic legaciese (1)
- bioindication (1)
- biomarker (1)
- bladder cancer (BCa) (1)
- bladder exstrophy-epispadias complex (1)
- breast cancer (1)
- brown bear (1)
- c-MET (1)
- cabazitaxel (1)
- carbapenem resistance (1)
- cardiac arrest (1)
- cardiac remodeling (1)
- case study (1)
- castration resistance (1)
- cataract surgery (1)
- cell lines (1)
- cell therapy (1)
- cell-free protein synthesis (1)
- characteristic species (1)
- chemorefractory metastatic colorectal cancer (1)
- children and adolescents (1)
- chronic total occlusion (1)
- cilia (1)
- cisplatin resistance (1)
- cloacal malformation (1)
- coastal geomorphology (1)
- colorectal cancer (1)
- complementary/alternative medicine (CAM) (1)
- computer tomography (1)
- computer-assisted (1)
- conical coupling (1)
- conometric connection (1)
- corneas (1)
- cryptic species (1)
- cytarabine dose (1)
- dE/dx (1)
- data quality (1)
- depression (1)
- deswelling (1)
- detector (1)
- diagnostic imaging (1)
- differentiating species (1)
- disease prevalence (1)
- docetaxel (1)
- docetaxel (DX) resistance (1)
- drug resistance (1)
- dual-energy (1)
- easyPACId (1)
- ectosomes (1)
- effective lens position (1)
- elderly (1)
- electrical resistivity tomography (1)
- electroencephalography (EEG) (1)
- eltrombopag (1)
- energy-dispersive x-ray spectroscopy (1)
- epigenomics (1)
- epiregulin (1)
- ethical trade-off (1)
- eutrophication (1)
- excitation (1)
- exosomes (1)
- experimental results (1)
- explainable AI (1)
- extinction (1)
- extracellular vesicles (1)
- fear conditioning (1)
- fibrotest (1)
- fluorine (1)
- foraminifera (1)
- foraminifers (1)
- forest classification (1)
- forest functional similarity (1)
- fragment-based screening (1)
- functional genetics (1)
- gadobutrol (1)
- gene family (1)
- genetic generalized epilepsy (1)
- genome evolution (1)
- geophysical prospections (1)
- germ cell tumors (1)
- glecaprevir (1)
- glioblastoma (1)
- glioblastoma survival (1)
- global change (1)
- graft rejection (1)
- graft-versus host (1)
- grasshopper communities (1)
- guidelines (1)
- habitat destruction (1)
- head-and-neck cancer (1)
- health information exchange (1)
- healthcare (1)
- heart failure (1)
- heavy ion experiments (1)
- heavy-ion collisions (1)
- hepatic encephalopathy (1)
- hepatitis C virus (1)
- hepatocellular carcinoma (1)
- high-pitch (1)
- highly-charged ions (1)
- histology (1)
- hospital exemption (1)
- human cytomegalovirus (1)
- human knockout model (1)
- hypertension, pulmonary (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitor (ICI) (1)
- immunity (1)
- immunohistochemistry (1)
- in vivo dosimetry (1)
- infection control (1)
- integrative taxonomy (1)
- interoperability (1)
- interventional radiology (1)
- intraarterial therapy (1)
- intrinsically disordered region (1)
- invasive species (1)
- iron chelation (1)
- ischemic type biliary lesions (1)
- keratoplasty (1)
- kidney formation (1)
- kinase inhibitor (1)
- knockout mouse (1)
- lamotrigine (1)
- learning (1)
- levetiracetam (1)
- liver fibrosis (1)
- liver metastases (1)
- liver metastasis (1)
- liver transplantation (1)
- livermetastases of colorectal cancer (1)
- local radiotherapy (1)
- locoregional chemotherapy (1)
- long non-coding RNA (1)
- low-dose imaging (1)
- mRNA active cancer immunotherapy (1)
- mRNA vaccine (1)
- mTOR (1)
- mTOR inhibitor (1)
- macrophage (1)
- magnetic gradiometry (1)
- marginal fit (1)
- marker (1)
- medial prefrontal cortex (mPFC) (1)
- memory consolidation and extinction (1)
- mesenchymal stromal cell (1)
- metastasis (1)
- metastatic prostate cancer (1)
- microdosing (1)
- microkeratome (1)
- microlaparoscopy (1)
- micropalaeontology (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- minimally invasive surgery (1)
- molecular characteristics (1)
- mortality (1)
- motility (1)
- multicenter study (1)
- multidetector computed tomography (1)
- multivariate mixed model (1)
- natural products (1)
- necroptosis (1)
- neovascularization, physiologic (1)
- neutralizing antibodies (1)
- nitrogen deposition (1)
- nocardia (1)
- nocardiosis (1)
- non-invasive fibrosis assessment (1)
- non-small cell lung cancer (1)
- nonstructural proteins (1)
- optical coherence tomography (1)
- orthology (1)
- orthopic liver transplantation (1)
- ovary (1)
- p+p collisions (1)
- pIOL (1)
- pediatric (1)
- pediatric patients (1)
- pediatric robotic surgery (1)
- personality (1)
- pharmacoresistance (1)
- phylogenetic community distance (1)
- phylogenetic signal (1)
- pibrentasvir (1)
- point shear wave elastography (1)
- portal vein (1)
- portosystemic shunt (1)
- predictive biomarkers (1)
- prognostic biomarker (1)
- prostate cancer (1)
- prostate cancer (PCa) (1)
- proteins (1)
- proteobacteria (1)
- proteomics (1)
- pseudoexfoliative syndrome (1)
- pulmonary embolism (1)
- pulmonary nocardiosis (1)
- qualitative research (1)
- quality control (1)
- quantum electrodynamics test (1)
- quark gluon plasma (1)
- radiation dosage (1)
- radiation dosimetry (1)
- radiation protection (1)
- radiomics (1)
- rare diseases (1)
- rats (1)
- re-exposure (1)
- rechallenge (1)
- recurrence pattern (1)
- refractory aGvHD (1)
- reintroduction (1)
- relativistic collisions (1)
- renal impairment (1)
- repeatability (1)
- reproducibility (1)
- resistance (1)
- retrospective trial (1)
- rigor (1)
- robotically assisted surgery (1)
- robotics (1)
- schizophrenia (1)
- sea-level indicator (1)
- semi-dry grassland (1)
- sequential ALK-inhibitor therapy (1)
- sex (1)
- shikonin (SHI) (1)
- simplified production (1)
- single subject classification (1)
- smart home (1)
- smart living (1)
- soil nutrients (1)
- song evolution (1)
- spectra (1)
- sphingolipids (1)
- spike protein (1)
- spontaneous portosystemic shunt (1)
- stage II/III colorectal cancer (1)
- standardization (1)
- steroid-resistant aGvHD (1)
- strong Coulomb field (1)
- structural habitat types (1)
- structural proteins (1)
- survival (1)
- temporal classification (1)
- testis (1)
- therapeutic anticoagulation (1)
- thrombopietin receptor agonist (1)
- thrombosis (1)
- tivantinib (1)
- transcranial magnetic stimulation (TMS) (1)
- transient elastography (1)
- transmission (1)
- transplantation (1)
- treatment resistance (1)
- tropical forests (1)
- trust (1)
- trustworthy AI (1)
- tumor microenvironment (1)
- tyrosine kinase inhibitor (TKI) (1)
- urinary tract development (1)
- uveal melanoma (1)
- valproic acid (1)
- variants of concern (1)
- vegetation-plot data (1)
- web of things (1)
- whole-genome sequencing (1)
- x-ray techniques (1)
- zebrafish development (1)
- Öffentlichkeit (1)
- ΔNp63 (1)
- Υ suppression (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1127)
- Frankfurt Institute for Advanced Studies (FIAS) (1059)
- Informatik (928)
- Medizin (177)
- Geowissenschaften (39)
- Institut für Ökologie, Evolution und Diversität (14)
- Biowissenschaften (13)
- Biodiversität und Klima Forschungszentrum (BiK-F) (10)
- Senckenbergische Naturforschende Gesellschaft (8)
- ELEMENTS (7)
Aim: To evaluate the ability of PillCamColon2 to visualize colonic segments missed by incomplete optical colonoscopy (OC) and to assess the diagnostic yield.
Methods: This prospective multicentre study included 81 patients from nine centres who underwent second-generation colon capsule endoscopy (CCE) following incomplete OC performed by an experienced gastroenterologist (> 1000 colonoscopies). Patients with stenosis were excluded. According to patient preferences, CCE was performed the following day (protocol A) after staying on clear liquids and 0.75 L Moviprep in the morning or within 30 d after new split-dose Moviprep (protocol B). Boosts consisted of 0.75 L and 0.25 L Moviprep, and phospho-soda was given as a rescue if the capsule was not excreted after seven hours.
Results: Seventy-four patients were analysed (51% of them in group A; 49% in group B). Bowel cleansing was adequate in 67% of cases, and CCE could visualize colonic segments missed by incomplete colonoscopy in 90% of patients under protocol A and 97% of patients under protocol B (P = 0.35, n.s.). Significant polyps including adenocarcinoma were detected in 24% of cases. Detection rates for all polyps and significant polyps per patient were similar in both protocols. Polyps were found predominantly in the right colon (86%) in segments that were not reached by OC. Extracolonic findings - such as reflux esophagitis, suspected Barrett esophagus, upper GI-bleeding, gastric polyps, gastric erosions and angiectasia - were detected in eight patients. PillCamColon2 capsule was retained in the ileum of one patient (1.4%) without symptoms and removed during an uneventful resection for unknown Crohn’s disease that was diagnosed as the cause of anemia, which was the indication for colonoscopy. CCE was well tolerated. One patient suffered from self-limiting vomiting after consuming the phospho-soda.
Conclusion: Second-generation CCE using a low-volume preparation is useful after incomplete OC, and it allows for the detection of additional relevant findings, but cleansing efficiency could be improved.
The TOM complex is the main entry point for precursor proteins into mitochondria. Precursor proteins containing targeting sequences are recognized by the TOM complex and imported into the mitochondria. We have determined the structure of the TOM core complex from Neurospora crassa by single-particle cryoEM at 3.3 Å resolution, showing its interaction with a bound presequence at 4 Å resolution, and of the TOM holo complex including the Tom20 receptor at 6-7 Å resolution. TOM is a transmembrane complex consisting of two β-barrels, three receptor subunits and three short transmembrane subunits. Tom20 has a transmembrane helix and a receptor domain on the cytoplasmic side. We propose that Tom20 acts as a dynamic gatekeeper, guiding precursor proteins into the pores of the TOM complex. We analyze the interactions of Tom20 with other TOM subunits, present insights into the structure of the TOM holo complex, and suggest a translocation mechanism.
Purpose
To assess the diagnostic value of different imaging modalities in distinguishing systemic vasculitis from other internal and immunological diseases.
Methods
This retrospective study included 134 patients with suspected vasculitis who underwent ultrasound, magnetic resonance imaging (MRI), or 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) between 01/2010 and 01/2019, finally consisting of 70 individuals with vasculitis. The main study parameter was the confirmation of the diagnosis using one of the three different imaging modalities, with the adjudicated clinical and histopathological diagnosis as the gold standard. A secondary parameter was the morphological appearance of the vessel affected by vasculitis.
Results
Patients with systemic vasculitis had myriad clinical manifestations with joint pain as the most common symptom. We found significant correlations between different imaging findings suggestive of vasculitis and the final adjudicated clinical diagnosis. In this context, on MRI, vessel wall thickening, edema, and diameter differed significantly between vasculitis and non-vasculitis groups (p < 0.05). Ultrasound revealed different findings that may serve as red flags in identifying patients with vasculitis, such as vascular occlusion or halo sign (p = 0.02 vs. non-vasculitis group). Interestingly, comparing maximal standardized uptake values from PET/CT examinations with vessel wall thickening or vessel diameter did not result in significant differences (p > 0.05).
Conclusions
We observed significant correlations between different imaging findings suggestive of vasculitis on ultrasound or MRI and the final adjudicated diagnosis. While ultrasound and MRI were considered suitable imaging methods for detecting and discriminating typical vascular changes, 18F-FDG PET/CT requires careful timing and patient selection given its moderate diagnostic accuracy.
Highlights
• Early reconstruction of injured cruciate ligaments improves functional outcomes.
• Modern CT imaging can be used to rapidly identify patients with injury to the cruciate ligaments and streamline therapeutic pathways.
• Dual-energy CT demonstrates superior diagnostic accuracy compared to single-energy CT.
Abstract
Background: This study aimed to evaluate the clinical utility of modern single and dual-energy computed tomography (CT) for assessing the integrity of the cruciate ligaments in patients that sustained acute trauma.
Methods: Patients who underwent single- or dual-energy CT followed by 3 Tesla magnetic resonance imaging (MRI) or knee joint arthroscopy between 01/2016 and 12/2022 were included in this retrospective, monocentric study. Three radiologists specialized in musculoskeletal imaging independently evaluated all CT images for the presence of injury to the cruciate ligaments. An MRI consensus reading of two experienced readers and arthroscopy provided the reference standard. Diagnostic accuracy parameters and area under the receiver operator characteristic curve (AUC) were the primary metrics for diagnostic performance.
Results: CT images of 204 patients (median age, 49 years; IQR 36 – 64; 113 males) were evaluated. Dual-energy CT yielded significantly higher diagnostic accuracy and AUC for the detection of injury to the anterior (94% [240/255] vs 75% [266/357] and 0.89 vs 0.66) and posterior cruciate ligaments (95% [243/255] vs 87% [311/357] and 0.90 vs 0.61) compared to single-energy CT (all parameters, p <.005). Diagnostic confidence and image quality were significantly higher in dual-energy CT compared to single-energy CT (all parameters, p <.005).
Conclusions: Modern dual-energy CT is readily available and can serve as a screening tool for detecting or excluding cruciate ligament injuries in patients with acute trauma. Accurate diagnosis of cruciate ligament injuries is crucial to prevent adverse outcomes, including delayed treatment, chronic instability, or long-term functional limitations.
Background: Dual-energy CT (DECT)-derived bone mineral density (BMD) of the distal radius and other CT-derived metrics related to bone health have been suggested for opportunistic osteoporosis screening and risk evaluation for sustaining distal radius fractures (DRFs).
Methods: The distal radius of patients who underwent DECT between 01/2016 and 08/2021 was retrospectively analyzed. Cortical Hounsfield Unit (HU), trabecular HU, cortical thickness, and DECT-based BMD were acquired from a non-fractured, metaphyseal area in all examinations. Receiver-operating characteristic (ROC) analysis was conducted to determine the area under the curve (AUC) values for predicting DRFs based on DECT-derived BMD, HU values, and cortical thickness. Logistic regression models were then employed to assess the associations of these parameters with the occurrence of DRFs.
Results: In this study, 263 patients (median age: 52 years; interquartile range: 36–64; 132 women; 192 fractures) were included. ROC curve analysis revealed a higher area under the curve (AUC) value for DECT-derived BMD compared to cortical HU, trabecular HU, and cortical thickness (0.91 vs. 0.61, 0.64, and 0.69, respectively; p <.001). Logistic regression models confirmed the association between lower DECT-derived BMD and the occurrence of DRFs (Odds Ratio, 0.83; p <.001); however, no influence was observed for cortical HU, trabecular HU, or cortical thickness.
Conclusions: DECT can be used to assess the BMD of the distal radius without dedicated equipment such as calibration phantoms to increase the detection rates of osteoporosis and stratify the individual risk to sustain DRFs. In contrast, assessing HU-based values and cortical thickness does not provide clinical benefit.
Glecaprevir/pibrentasvir, a pangenotypic, direct-acting antiviral combination approved for chronic hepatitis C virus treatment, has limited real-world evidence supporting 8-week therapy in compensated cirrhosis. We investigated effectiveness and safety of 187 hepatitis C virus-infected, treatment-naïve, patients with compensated cirrhosis receiving 8-week glecaprevir/pibrentasvir therapy in the German Hepatitis C-Registry between 2 August 2017 and 1 January 2020. Sustained virologic response was 98.4% (127/129) in the per-protocol analysis (excluding patients lost to follow-up or who discontinued treatment due to compliance) and was 85.8% (127/148) in patients with data available in an intention-to-treat analysis. Nineteen patients were lost to follow-up; nine genotype 3 patients, nine nongenotype 3 patients and one mixed genotype patient. One patient relapsed, and one died, unrelated to treatment. Adverse events (>5%) were fatigue and headache. Two serious adverse events occurred; no adverse events resulted in drug discontinuation. An 8-week glecaprevir/pibrentasvir therapy was effective and well-tolerated in this real-world analysis.
Highlights
• Assessment of coronary artery plaque burden according to the CAC-DRS Score correlated well with pulmonary involvement of SARS-CoV-2 pneumonia (min. r=0.81, 95% CI 0.76 to 0.86).
• Visual and quantitative CAC-DRS Score of coronary artery plaque burden provided independent prognostic information on all-cause mortality in patients with SARS-CoV-2 pneumonia (p=0.0016 and p<0.0001, respectively).
• Incorporating CAC-DRS Score and pulmonary involvement into clinical decision making revealed great potential to discriminate patients with fatal outcomes from a mild course of disease (AUC 0.938, 95% CI 0.89 to 0.97) and the need for intensive care treatment (AUC 0.801, 95% CI 0.77 to 0.83).
Purpose: To assess and correlate pulmonary involvement and outcome of SARS-CoV-2 pneumonia with the degree of coronary plaque burden based on the CAC-DRS classification (Coronary Artery Calcium Data and Reporting System).
Methods: This retrospective study included 142 patients with confirmed SARS-CoV-2 pneumonia (58 ± 16 years; 57 women) who underwent non-contrast CT between January 2020 and August 2021 and were followed up for 129 ± 72 days. One experienced blinded radiologist analyzed CT series for the presence and extent of calcified plaque burden according to the visual and quantitative HU-based CAC-DRS Score. Pulmonary involvement was automatically evaluated with a dedicated software prototype by another two experienced radiologists and expressed as Opacity Score.
Results: CAC-DRS Scores derived from visual and quantitative image evaluation correlated well with the Opacity Score (r=0.81, 95% CI 0.76-0.86, and r=0.83, 95% CI 0.77-0.89, respectively; p<0.0001) with higher correlation in severe than in mild stage SARS-CoV-2 pneumonia (p<0.0001). Combined, CAC-DRS and Opacity Scores revealed great potential to discriminate fatal outcomes from a mild course of disease (AUC 0.938, 95% CI 0.89-0.97), and the need for intensive care treatment (AUC 0.801, 95% CI 0.77-0.83). Visual and quantitative CAC-DRS Scores provided independent prognostic information on all-cause mortality (p=0.0016 and p<0.0001, respectively), both in univariate and multivariate analysis.
Conclusions: Coronary plaque burden is strongly correlated to pulmonary involvement, adverse outcome, and death due to respiratory failure in patients with SARS-CoV-2 pneumonia, offering great potential to identify individuals at high risk.
Rationale and Objectives: Lumbar disk degeneration is a common condition contributing significantly to back pain. The objective of the study was to evaluate the potential of dual-energy CT (DECT)-derived collagen maps for the assessment of lumbar disk degeneration.
Patients and Methods: We conducted a retrospective analysis of 127 patients who underwent dual-source DECT and MRI of the lumbar spine between 07/2019 and 10/2022. The level of lumbar disk degeneration was categorized by three radiologists as follows: no/mild (Pfirrmann 1&2), moderate (Pfirrmann 3&4), and severe (Pfirrmann 5). Recall (sensitivity) and accuracy of DECT collagen maps were calculated. Intraclass correlation coefficient (ICC) was used to evaluate inter-reader reliability. Subjective evaluations were performed using 5-point Likert scales for diagnostic confidence and image quality.
Results: We evaluated a total of 762 intervertebral disks from 127 patients (median age, 69.7 (range, 23.0–93.7), female, 56). MRI identified 230 non/mildly degenerated disks (30.2%), 484 moderately degenerated disks (63.5%), and 48 severely degenerated disks (6.3%). DECT collagen maps yielded an overall accuracy of 85.5% (1955/2286). Recall (sensitivity) was 79.3% (547/690) for the detection of no/mild lumbar disk degeneration, 88.7% (1288/1452) for the detection of moderate disk degeneration, and 83.3% (120/144) for the detection of severe disk degeneration (ICC = 0.9). Subjective evaluations of DECT collagen maps showed high diagnostic confidence (median 4) and good image quality (median 4).
Conclusion: The use of DECT collagen maps to distinguish different stages of lumbar disk degeneration may have clinical significance in the early diagnosis of disk-related pathologies in patients with contraindications for MRI or in cases of unavailability of MRI.
Rationale and Objectives: Bone non-union is a serious complication of distal radius fractures (DRF) that can result in functional limitations and persistent pain. However, no accepted method has been established to identify patients at risk of developing bone non-union yet. This study aimed to compare various CT-derived metrics for bone mineral density (BMD) assessment to identify predictive values for the development of bone non-union.
Materials and Methods: CT images of 192 patients with DRFs who underwent unenhanced dual-energy CT (DECT) of the distal radius between 03/2016 and 12/2020 were retrospectively identified. Available follow-up imaging and medical health records were evaluated to determine the occurrence of bone non-union. DECT-based BMD, trabecular Hounsfield unit (HU), cortical HU and cortical thickness ratio were measured in normalized non-fractured segments of the distal radius.
Results: Patients who developed bone non-union were significantly older (median age 72 years vs. 54 years) and had a significantly lower DECT-based BMD (median 68.1 mg/cm3 vs. 94.6 mg/cm3, p < 0.001). Other metrics (cortical thickness ratio, cortical HU, trabecular HU) showed no significant differences. ROC and PR curve analyses confirmed the highest diagnostic accuracy for DECT-based BMD with an area under the curve (AUC) of 0.83 for the ROC curve and an AUC of 0.46 for the PR curve. In logistic regression models, DECT-based BMD was the sole metric significantly associated with bone non-union.
Conclusion: DECT-derived metrics can accurately predict bone non-union in patients who sustained DRF. The diagnostic performance of DECT-based BMD is superior to that of HU-based metrics and cortical thickness ratio.
Objectives: To assess the impact of noise-optimised virtual monoenergetic imaging (VMI+) on image quality and diagnostic evaluation in abdominal dual-energy CT scans with impaired portal-venous contrast.
Methods: We screened 11,746 patients who underwent portal-venous abdominal dual-energy CT for cancer staging between 08/2014 and 11/2019 and identified those with poor portal-venous contrast.
Standard linearly-blended image series and VMI+ image series at 40, 50, and 60 keV were reconstructed. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of abdominal organs and vascular structures were calculated. Image noise, image contrast and overall image quality were rated by three radiologists using 5-point Likert scale.
Results: 452 of 11,746 (4%) exams were poorly opacified. We excluded 190 cases due to incomplete datasets or multiple exams of the same patient with a final study group of 262. Highest CNR values in all abdominal organs (liver, 6.4 ± 3.0; kidney, 17.4 ± 7.5; spleen, 8.0 ± 3.5) and vascular structures (aorta, 16.0 ± 7.3; intrahepatic vein, 11.3 ± 4.7; portal vein, 15.5 ± 6.7) were measured at 40 keV VMI+ with significantly superior values compared to all other series. In subjective analysis, highest image contrast was seen at 40 keV VMI+ (4.8 ± 0.4), whereas overall image quality peaked at 50 keV VMI+ (4.2 ± 0.5) with significantly superior results compared to all other series (p < 0.001).
Conclusions: Image reconstruction using VMI+ algorithm at 50 keV significantly improves image contrast and image quality of originally poorly opacified abdominal CT scans and reduces the number of non-diagnostic scans.
Advances in knowledge: We validated the impact of VMI+ reconstructions in poorly attenuated DECT studies of the abdomen in a big data cohort.
Background: Tuberous sclerosis complex (TSC) is a monogenetic, multisystem disorder characterized by benign growths due to TSC1 or TSC2 mutations. This German multicenter study estimated the costs and related cost drivers associated with organ manifestations in adults with TSC.
Methods: A validated, three-month, retrospective questionnaire assessed the sociodemographic and clinical characteristics, organ manifestations, direct, indirect, out-of-pocket (OOP), and nursing care-level costs among adult individuals with TSC throughout Germany from a societal perspective (costing year: 2019).
Results: We enrolled 192 adults with TSC (mean age: 33.4 ± 12.7 years; range: 18–78 years, 51.6% [n = 99] women). Reported TSC disease manifestations included skin (94.8%) and kidney and urinary tract (74%) disorders, epilepsy (72.9%), structural brain defects (67.2%), psychiatric disorders (50.5%), heart and circulatory system disorders (50.5%), and lymphangioleiomyomatosis (11.5%). TSC1 and TSC2 mutations were reported in 16.7% and 25% of respondents, respectively. Mean direct health care costs totaled EUR 6452 (median EUR 1920; 95% confidence interval [CI] EUR 5533–7422) per patient over three months. Medication costs represented the major direct cost category (77% of total direct costs; mean EUR 4953), and mechanistic target of rapamycin (mTOR) inhibitors represented the largest share (68%, EUR 4358). Mean antiseizure drug (ASD) costs were only EUR 415 (6%). Inpatient costs (8%, EUR 518) and outpatient treatment costs (7%; EUR 467) were important further direct cost components. The mean care grade allowance as an approximator of informal nursing care costs was EUR 929 (median EUR 0; 95% CI EUR 780–1083) over three months. Mean indirect costs totaled EUR 3174 (median EUR 0; 95% CI EUR 2503–3840) among working-age individuals (< 67 years in Germany). Multiple regression analyses revealed mTOR inhibitor use and persistent seizures as independent cost-driving factors for total direct costs. Older age and disability were independent cost-driving factors for total indirect costs, whereas epilepsy, psychiatric disease, and disability were independent cost-driving factors for nursing care costs.
Conclusions: This three-month study revealed substantial direct healthcare, indirect healthcare, and medication costs associated with TSC in Germany. This study highlights the spectrum of organ manifestations and their associated treatment needs in the German healthcare setting. Trial registration: DRKS, DRKS00016045. Registered 01 March 2019, http://www.drks.de/DRKS00016045.